Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain ; day:25 ; month:4 ; year:2024 ; pages:1-9
Molecular biotechnology ; (25.4.2024), 1-9
- Creator
-
Kılıç, Gamze
Demirkan, Elif
Yücel, Fatıma
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12033-024-01138-1
- URN
-
urn:nbn:de:101:1-2407120652268.835024467508
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kılıç, Gamze
- Demirkan, Elif
- Yücel, Fatıma
- SpringerLink (Online service)
Other Objects (12)
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Monoclonal antibody therapy
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report
Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Monoclonal antibody therapy
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report
Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Monoclonal antibody therapy
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report
Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays
Neutralizing antibody titres in SARS-CoV-2 infections
The early antibody response to SARS-Cov-2 infection